Erste Asset Management GmbH
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2024532
VIENNA, C4
Position in REGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$24,140,974
-$20,060,987 QoQ
Shares Held
38,716
-32.3% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#189
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. REGN ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,154,900 | $79,968,339 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
110,210 | $59,177,259 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,568,945 | $46,163,941 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
76,558 | $38,028,654 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
834,000 | $29,515,260 | |
| 6 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
2,536,939 | $25,141,065 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
38,716 | $24,140,974 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
205,000 | $23,999,350 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,140,974 | 38,716 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $44,201,961 | 57,209 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $40,175,061 | 52,049 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $27,402,789 | 48,736 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $28,033,425 | 53,397 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $23,487,439 | 37,033 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,765,310 | 40,382 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $42,721,342 | 40,639 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $40,814,647 | 38,833 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $40,374,530 | 41,948 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $35,904,495 | 40,880 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $31,659,271 | 38,470 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $28,635,974 | 39,853 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $32,406,664 | 39,440 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $23,194,460 | 32,148 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $23,514,577 | 34,135 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $19,671,624 | 33,278 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $22,489,822 | 32,201 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $21,001,829 | 33,256 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $21,163,144 | 34,970 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $17,577,253 | 31,470 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $15,670,396 | 33,120 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $15,879,825 | 32,870 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $19,967,352 | 35,670 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $22,451,400 | 36,000 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $4,638,755 | 9,500 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||